1、Pharmaceutical Supply Chain Vision StudyTechnology-led Transparency Drives ResiliencyRising consumer expectations and industry requirements have precipitated supply chain improvements for new levels of agility,visibility and safety.2 zebra technologiesVision Study ReportPharmaceutical Supply ChainCo

2、ntents The Story in Numbers 3One-Minute Read 4Market Watch:The Impact of Public Health Crises and Increased Regulation 5Supply Chain Stability Heightens Patient Satisfaction 6Patients Want More Transparency and Education 7 Pharmaceutical Organizations Transition from Reactive to Predictive Operation

3、s 9 Increasing Confidence and Enabling Agility 10 Technology Investment Drives Supply Chain Resiliency 11 Regional Findings 13 Enabling a Safe,Stable and Reliable Supply Chain 14 About the Study Zebras Pharmaceutical Supply Chain Vision Study was conducted among a global audience of over 3,500 patie

4、nts and pharmaceutical industry decision-makers to evaluate perceived supply chain stability,gauge supply chain responsibility and trust in its entities,and identify needs for improving supply chain visibility and transparency.Respondents were surveyed in Asia Pacific,Europe,Latin America and North

5、America.Patients are adults with medical health issues requiring prescription medication or treatment that was filled at a pharmacy.Pharmaceutical industry decision-makers are executive-level leaders in healthcare,manufacturing,pharmacy retail,or transportation and logistics organizations who mainta

6、in operations in the pharmaceutical or biopharmaceutical supply chain.All data was collected and tabulated by third-party research firm Azure Knowledge Corporation.3 zebra technologiesVision Study ReportPharmaceutical Supply ChainThe Story in NumbersTop Trends:Comparing Patient Perceptions Against I